• Report Adverse Event or Product Quality Complaint
  • Global Site
AstraZeneca Medical Information
  • Prescribing Information
  • Resources
    • Congress Library
    • Our Pipeline
    • AZ Clinical Trials
    • Externally Sponsored Scientific Research
  • Connect
    • Send MIR
    • Give Feedback

Search Medical Information

American Heart Association (AHA 2024)

November 16 - 18, 2024

  1. FARXIGA (dapagliflozin)
  2. WAINUA (eplontersen)
  3. LOKELMA (sodium zirconium cyclosilicate)
  4. Heart Failure

pdf

Effect of Time Since Heart Failure Diagnosis or Hospitalisation on the Cost-effectiveness of Dapagliflozin in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction

html

Galectin-3 and Progression of Kidney Disease in Patients with Type 2 Diabetes Mellitus: Analyses From the DECLARE-TIMI 58 Trial

html

Defining “Advanced Heart Failure” across the Ejection Fraction Spectrum in DAPA-HF and DELIVER

html

Age, Adiposity-Related Anthropometrics, and Clinical Outcomes in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Participant-Level Pooled Analysis of Randomized Trials

html

Sex, Adiposity-Related Anthropometrics, and Clinical Outcomes in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Participant-Level Pooled Analysis of Randomized Trials

PDF

External Validation of EchoNet-LVH, a Deep Learning Model for Cardiac Amyloidosis for Association with Cardiomyopathy.

pdf

Hyperkalemia-Related Hospitalization Associated with Short-Term vs. Long-Term Outpatient SZC Therapy Among RAASi Users: The GALVANIZE Outcome study

HTML

Effects of Sodium Zirconium Cyclosilicate on Optimizing Mineralocorticoid Receptor Antagonist use in Patients with Heart Failure and Reduced Ejection Fraction and Hyperkalemia: Results from REALIZE-K Randomized Controlled Trial

pdf

Sodium zirconium cyclosilicate and MRA optimization in heart failure with reduced ejection fraction and hyperkalemia: main results from REALIZE-K randomized controlled trial

pdf

Myeloperoxidase Inhibition with Mitiperstat in HFpEF and HFmrEF: Primary Results of the ENDEAVOR Randomized Clinical Trial

html

Polygenic Risk in Heart Failure – Evaluating the Ability of a Polygenic Risk Score to Identify Risk of Future Heart Failure Events in 60,000 Patients from 6 TIMI Randomized Trials

HTML

Obesity and Risk of Kidney Outcomes in Heart Failure with Preserved Ejection Fraction: A Participant-Level Pooled Analysis of 4 Contemporary Trials

html

Hispanic/Latino Patients with Heart Failure with Preserved Ejection Fraction: A Participant Level Pooled Analysis of 3 Contemporary Trials

Need Help?

Contact Us

Send MIR

Submit a Medical Information Request

Disclaimer

Some content may have changed since publication. Some links may require registration/login to access the content. Any attached publications and/or any tables or figures derived from the publications are copyright-protected works. AstraZeneca has obtained permission from the copyright owner to use this work on this site. You may not reproduce, prepare derivative works from, display or distribute this work unless you obtain the permission of the copyright owner, or as otherwise might be permitted by law.

AstraZeneca Logo

This platform is provided as service to healthcare professionals by AstraZeneca Philippines, for medical educational purposes only.

©2024 AstraZeneca. All rights reserved.

PH-10554.

Last Updated 5/24

Contact Us

About Us

AstraZeneca.com

Survey Feedback

Privacy Notice

Legal Notice

Cookie Notice

Global Site

Report Adverse Event or Product Quality Complaint

Privacy NoticeLegal NoticeCookie Notice

Welcome to AstraZeneca Philippines Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the Philippines, for medical educational purposes only. AstraZeneca does not engage in the promotion of unregistered products or unapproved indications. The dissemination of this information may be subject to different medical and regulatory requirements in other countries

Are you a healthcare professional practicing in the Philippines?

No